25 XP   0   0   10

Aspira Womens Health Inc
Buy, Hold or Sell?

Let's analyse Aspira Womens Health Inc together

PenkeI guess you are interested in Aspira Womens Health Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Aspira Womens Health Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Aspira Womens Health Inc

I send you an email if I find something interesting about Aspira Womens Health Inc.

Quick analysis of Aspira Womens Health Inc (30 sec.)










What can you expect buying and holding a share of Aspira Womens Health Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
12.8%

What is your share worth?

Current worth
$-0.19
Expected worth in 1 year
$-0.54
How sure are you?
28.2%

+ What do you gain per year?

Total Gains per Share
$-0.34
Return On Investment
-10.4%

For what price can you sell your share?

Current Price per Share
$3.33
Expected price per share
$2.3087 - $4.2177
How sure are you?
50%

1. Valuation of Aspira Womens Health Inc (5 min.)




Live pricePrice per Share (EOD)

$3.33

Intrinsic Value Per Share

$-16.33 - $-5.14

Total Value Per Share

$-16.52 - $-5.33

2. Growth of Aspira Womens Health Inc (5 min.)




Is Aspira Womens Health Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.3m$8.2m-$9.3m-793.8%

How much money is Aspira Womens Health Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.3m-$4.6m$1.2m38.5%
Net Profit Margin-150.1%-215.4%--

How much money comes from the company's main activities?

3. Financial Health of Aspira Womens Health Inc (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#133 / 145

Most Revenue
#118 / 145

Most Profit
#90 / 145

Most Efficient
#117 / 145

What can you expect buying and holding a share of Aspira Womens Health Inc? (5 min.)

Welcome investor! Aspira Womens Health Inc's management wants to use your money to grow the business. In return you get a share of Aspira Womens Health Inc.

What can you expect buying and holding a share of Aspira Womens Health Inc?

First you should know what it really means to hold a share of Aspira Womens Health Inc. And how you can make/lose money.

Speculation

The Price per Share of Aspira Womens Health Inc is $3.3266. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Aspira Womens Health Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Aspira Womens Health Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.19. Based on the TTM, the Book Value Change Per Share is $-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.42 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Aspira Womens Health Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.25-7.5%-0.27-8.2%-0.49-14.6%-0.45-13.4%0.205.9%
Usd Book Value Change Per Share-0.14-4.2%-0.09-2.6%-0.42-12.7%-0.04-1.2%-0.05-1.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.154.4%
Usd Total Gains Per Share-0.14-4.2%-0.09-2.6%-0.42-12.7%-0.04-1.2%0.092.8%
Usd Price Per Share3.10-3.92-0.41-2.56-2.03-
Price to Earnings Ratio-3.10--3.67--0.21--1.63--1.33-
Price-to-Total Gains Ratio-22.43--185.89--1.05--35.07--18.32-
Price to Book Ratio-16.18--64.66-1.75--8.43--2.86-
Price-to-Total Gains Ratio-22.43--185.89--1.05--35.07--18.32-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.3266
Number of shares300
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.09-0.04
Usd Total Gains Per Share-0.09-0.04
Gains per Quarter (300 shares)-25.86-12.17
Gains per Year (300 shares)-103.43-48.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-103-1130-49-59
20-207-2160-97-108
30-310-3190-146-157
40-414-4220-195-206
50-517-5250-243-255
60-621-6280-292-304
70-724-7310-341-353
80-827-8340-390-402
90-931-9370-438-451
100-1034-10400-487-500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%0.019.00.00.0%3.036.00.07.7%4.089.00.04.3%
Book Value Change Per Share0.03.00.00.0%0.011.00.00.0%3.015.01.015.8%8.028.03.020.5%19.068.06.020.4%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%5.00.034.012.8%5.00.088.05.4%
Total Gains per Share0.03.00.00.0%0.011.00.00.0%3.015.01.015.8%11.025.03.028.2%22.065.06.023.7%

Fundamentals of Aspira Womens Health Inc

About Aspira Womens Health Inc

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering. Its product pipeline includes OvaWatch, a non-invasive blood-based risk assessment test to determine ovarian cancer risk for patients with an adnexal mass; and Endocheck, an in-development non-invasive blood test designed as an aid in the identification of endometriosis for patients with suspected endometriosis earlier in their prognosis journey. In addition, the company operates Aspira Synergy, a testing platform and cloud service; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. It has a research agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas.

Fundamental data was last updated by Penke on 2024-04-11 01:37:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Aspira Womens Health Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Aspira Womens Health Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -145.0% means that $-1.45 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Aspira Womens Health Inc:

  • The MRQ is -145.0%. The company is making a huge loss. -2
  • The TTM is -150.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-145.0%TTM-150.1%+5.1%
TTM-150.1%YOY-215.4%+65.3%
TTM-150.1%5Y-322.7%+172.6%
5Y-322.7%10Y-509.5%+186.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-145.0%-6.7%-138.3%
TTM-150.1%-6.7%-143.4%
YOY-215.4%0.3%-215.7%
5Y-322.7%-1.5%-321.2%
10Y-509.5%-3.4%-506.1%
1.1.2. Return on Assets

Shows how efficient Aspira Womens Health Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • -49.3% Return on Assets means that Aspira Womens Health Inc generated $-0.49 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Aspira Womens Health Inc:

  • The MRQ is -49.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -44.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-49.3%TTM-44.6%-4.8%
TTM-44.6%YOY-28.5%-16.1%
TTM-44.6%5Y-27.3%-17.3%
5Y-27.3%10Y-27.5%+0.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-49.3%-1.3%-48.0%
TTM-44.6%-1.3%-43.3%
YOY-28.5%-0.9%-27.6%
5Y-27.3%-0.5%-26.8%
10Y-27.5%-0.9%-26.6%
1.1.3. Return on Equity

Shows how efficient Aspira Womens Health Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • 0.0% Return on Equity means Aspira Womens Health Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Aspira Womens Health Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-222.2%+222.2%
TTM-5Y-68.4%+68.4%
5Y-68.4%10Y-56.1%-12.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--0.5%+0.5%
TTM--0.0%
YOY-222.2%0.3%-222.5%
5Y-68.4%-1.4%-67.0%
10Y-56.1%-2.3%-53.8%

1.2. Operating Efficiency of Aspira Womens Health Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Aspira Womens Health Inc is operating .

  • Measures how much profit Aspira Womens Health Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of -194.1% means the company generated $-1.94  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Aspira Womens Health Inc:

  • The MRQ is -194.1%. The company is operating very inefficient. -2
  • The TTM is -198.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-194.1%TTM-198.3%+4.2%
TTM-198.3%YOY-343.8%+145.5%
TTM-198.3%5Y-360.9%+162.6%
5Y-360.9%10Y-531.2%+170.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-194.1%-6.2%-187.9%
TTM-198.3%0.5%-198.8%
YOY-343.8%4.0%-347.8%
5Y-360.9%3.7%-364.6%
10Y-531.2%-1.3%-529.9%
1.2.2. Operating Ratio

Measures how efficient Aspira Womens Health Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 2.94 means that the operating costs are $2.94 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Aspira Womens Health Inc:

  • The MRQ is 2.941. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.844. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.941TTM2.844+0.097
TTM2.844YOY4.438-1.594
TTM2.8445Y4.579-1.735
5Y4.57910Y6.266-1.688
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9411.280+1.661
TTM2.8441.304+1.540
YOY4.4381.236+3.202
5Y4.5791.242+3.337
10Y6.2661.205+5.061

1.3. Liquidity of Aspira Womens Health Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Aspira Womens Health Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.03 means the company has $1.03 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Aspira Womens Health Inc:

  • The MRQ is 1.031. The company is just able to pay all its short-term debts.
  • The TTM is 1.258. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.031TTM1.258-0.227
TTM1.258YOY2.753-1.495
TTM1.2585Y4.111-2.852
5Y4.11110Y4.135-0.024
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0312.111-1.080
TTM1.2582.298-1.040
YOY2.7532.599+0.154
5Y4.1113.012+1.099
10Y4.1353.081+1.054
1.3.2. Quick Ratio

Measures if Aspira Womens Health Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.79 means the company can pay off $0.79 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Aspira Womens Health Inc:

  • The MRQ is 0.792. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.061. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.792TTM1.061-0.269
TTM1.061YOY2.526-1.465
TTM1.0615Y3.914-2.853
5Y3.91410Y3.945-0.030
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7921.204-0.412
TTM1.0611.319-0.258
YOY2.5261.602+0.924
5Y3.9141.943+1.971
10Y3.9452.203+1.742

1.4. Solvency of Aspira Womens Health Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Aspira Womens Health Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Aspira Womens Health Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 1.38 means that Aspira Womens Health Inc assets are financed with 137.8% credit (debt) and the remaining percentage (100% - 137.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Aspira Womens Health Inc:

  • The MRQ is 1.378. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.174. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.378TTM1.174+0.204
TTM1.174YOY0.621+0.553
TTM1.1745Y0.507+0.667
5Y0.50710Y0.414+0.093
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3780.429+0.949
TTM1.1740.407+0.767
YOY0.6210.394+0.227
5Y0.5070.450+0.057
10Y0.4140.450-0.036
1.4.2. Debt to Equity Ratio

Measures if Aspira Womens Health Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Aspira Womens Health Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY4.081-4.081
TTM-5Y1.155-1.155
5Y1.15510Y0.840+0.314
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.606-0.606
TTM-0.571-0.571
YOY4.0810.631+3.450
5Y1.1550.658+0.497
10Y0.8400.735+0.105

2. Market Valuation of Aspira Womens Health Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Aspira Womens Health Inc generates.

  • Above 15 is considered overpriced but always compare Aspira Womens Health Inc to the Diagnostics & Research industry mean.
  • A PE ratio of -3.10 means the investor is paying $-3.10 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Aspira Womens Health Inc:

  • The EOD is -3.323. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.097. Based on the earnings, the company is expensive. -2
  • The TTM is -3.674. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.323MRQ-3.097-0.226
MRQ-3.097TTM-3.674+0.576
TTM-3.674YOY-0.215-3.459
TTM-3.6745Y-1.634-2.039
5Y-1.63410Y-1.328-0.307
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-3.323-0.235-3.088
MRQ-3.097-0.395-2.702
TTM-3.674-0.284-3.390
YOY-0.2150.002-0.217
5Y-1.6344.834-6.468
10Y-1.3285.200-6.528
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Aspira Womens Health Inc:

  • The EOD is -2.965. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.763. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.577. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.965MRQ-2.763-0.202
MRQ-2.763TTM-3.577+0.813
TTM-3.577YOY-0.190-3.387
TTM-3.5775Y-1.780-1.797
5Y-1.78010Y-1.647-0.133
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-2.965-0.277-2.688
MRQ-2.763-0.441-2.322
TTM-3.577-1.389-2.188
YOY-0.190-2.030+1.840
5Y-1.780-1.446-0.334
10Y-1.647-1.971+0.324
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Aspira Womens Health Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of -16.18 means the investor is paying $-16.18 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Aspira Womens Health Inc:

  • The EOD is -17.363. Based on the equity, the company is expensive. -2
  • The MRQ is -16.180. Based on the equity, the company is expensive. -2
  • The TTM is -64.655. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.363MRQ-16.180-1.183
MRQ-16.180TTM-64.655+48.475
TTM-64.655YOY1.749-66.405
TTM-64.6555Y-8.431-56.224
5Y-8.43110Y-2.857-5.574
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-17.3631.897-19.260
MRQ-16.1802.222-18.402
TTM-64.6552.168-66.823
YOY1.7493.041-1.292
5Y-8.4313.477-11.908
10Y-2.8574.125-6.982
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Aspira Womens Health Inc.

3.1. Institutions holding Aspira Womens Health Inc

Institutions are holding 9.091% of the shares of Aspira Womens Health Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc1.89620196007131627.1984
2023-12-31National Asset Management Inc1.73530.01971793715399743.0687
2023-12-31BlackRock Inc0.6072062766-403-0.638
2023-12-31Geode Capital Management, LLC0.5546057329557110.7636
2023-12-31Northern Trust Corp0.348703604925047227.6586
2023-12-31Bank of America Corp0.28230291831130863.2615
2023-12-31Northeast Financial Consultants, Inc0.22670.00532343600
2023-12-31State Street Corporation0.1765018249220013.708
2023-12-31Squarepoint Ops LLC0.14860.000115365153650
2023-12-31M&T Bank Corp0.14510.00021499900
2023-12-31HRT FINANCIAL LLC0.1090.000311262112620
2023-12-31Royal Bank of Canada0.09010931793170
2023-12-31Morgan Stanley - Brokerage Accounts0.022022741677.926
2023-12-31Advisor Group Holdings, Inc.0.021702239-2655-54.2501
2023-12-31JPMorgan Chase & Co0.02010207440.1932
2023-12-31Tower Research Capital LLC0.0180.000118641444343.8095
2023-12-31Castleview Partners, LLC0.01270.0038131600
2023-12-31Operose Advisors LLC0.00970.0016100000
2023-12-31Northwestern Mutual Wealth Management Co0.004804934930
2023-12-31UBS Group AG0.0037038100
Total 6.4330.0311664974+146279+22.0%

3.2. Funds holding Aspira Womens Health Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.57890.000119490600
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.62950.00037770300
2024-02-29Fidelity Extended Market Index0.29440.000436347-176-0.4819
2023-09-30BlackRock Extended Mkt Composite0.07850.0004968700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.07680.000694805837160.2251
2024-02-29Fidelity Series Total Market Index0.07610.00019393-820-8.029
2024-03-31BlackRock Extended Equity Market K0.06850.0002845430.0355
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.06170.000676144693160.6642
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05530.0005682700
2023-12-31Northern Trust Extended Eq Market Idx0.05530.0005682700
2024-02-29Fidelity Total Market Index0.05270650400
2024-02-29Fidelity Nasdaq Composite Index0.03470.0001427800
2024-02-29Vanguard Balanced Index Inv0.02690331800
2023-12-31SSgA U.S. Extended Market Index Class I0.01490.0003183500
2024-03-31State St US Extended Mkt Indx NL Cl C0.01490.0003183500
2024-02-29Spartan Total Market Index Pool E0.01390171200
2024-03-31BlackRock U.S. Equity Market F0.012501549150.9778
2024-02-29Vanguard U.S. Eq Idx £ Acc0.0120148000
2024-02-29Spartan Extended Market Index Pool E0.01020.0002126317616.1914
2024-03-31Extended Equity Market Fund M0.00840.00021043-2-0.1914
Total 3.17610.0048392055+9726+2.5%

3.3. Insider Transactions

Insiders are holding 38.842% of the shares of Aspira Womens Health Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-06Minh Hoang MerchantSELL9803.37
2023-12-06Nicole SandfordBUY50003.36
2023-09-08Torsten HombeckBUY22464.3
2023-07-24Jack W SchulerBUY1818002.75
2023-07-24Nicole SandfordBUY125633.98
2023-07-24Ryan Thinh PhanBUY6283.98
2023-07-24Torsten HombeckBUY7543.98
2023-07-24Veronica Gh JordanBUY37693.98

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Aspira Womens Health Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.138-0.086-38%-0.424+207%-0.041-71%-0.053-62%
Book Value Per Share---0.192-0.096-50%0.665-129%1.250-115%1.037-118%
Current Ratio--1.0311.258-18%2.753-63%4.111-75%4.135-75%
Debt To Asset Ratio--1.3781.174+17%0.621+122%0.507+172%0.414+233%
Debt To Equity Ratio----0%4.081-100%1.155-100%0.840-100%
Dividend Per Share----0%-0%-0%0.146-100%
Eps---0.250-0.273+9%-0.485+94%-0.445+78%0.197-227%
Free Cash Flow Per Share---0.280-0.276-2%-0.565+101%-0.428+53%-0.352+26%
Free Cash Flow To Equity Per Share---0.203-0.133-34%-0.391+93%-0.011-94%-0.047-77%
Gross Profit Margin--1.0001.375-27%-0.333+133%1.125-11%1.309-24%
Intrinsic Value_10Y_max---5.141--------
Intrinsic Value_10Y_min---16.328--------
Intrinsic Value_1Y_max---1.280--------
Intrinsic Value_1Y_min---2.018--------
Intrinsic Value_3Y_max---3.264--------
Intrinsic Value_3Y_min---5.768--------
Intrinsic Value_5Y_max---4.545--------
Intrinsic Value_5Y_min---9.167--------
Market Cap41063883.060+7%38266710.00048430019.000-21%5117555.258+648%31541254.506+21%25111919.145+52%
Net Profit Margin---1.450-1.501+4%-2.154+49%-3.227+123%-5.095+251%
Operating Margin---1.941-1.983+2%-3.438+77%-3.609+86%-5.312+174%
Operating Ratio--2.9412.844+3%4.438-34%4.579-36%6.266-53%
Pb Ratio-17.363-7%-16.180-64.655+300%1.749-1025%-8.431-48%-2.857-82%
Pe Ratio-3.323-7%-3.097-3.674+19%-0.215-93%-1.634-47%-1.328-57%
Price Per Share3.327+7%3.1003.923-21%0.415+648%2.555+21%2.034+52%
Price To Free Cash Flow Ratio-2.965-7%-2.763-3.577+29%-0.190-93%-1.780-36%-1.647-40%
Price To Total Gains Ratio-24.070-7%-22.431-185.885+729%-1.050-95%-35.072+56%-18.322-18%
Quick Ratio--0.7921.061-25%2.526-69%3.914-80%3.945-80%
Return On Assets---0.493-0.446-10%-0.285-42%-0.273-45%-0.275-44%
Return On Equity----0%-2.2220%-0.6840%-0.5610%
Total Gains Per Share---0.138-0.086-38%-0.424+207%-0.041-71%0.094-248%
Usd Book Value---2365000.000-1184000.000-50%8214500.000-129%15426000.000-115%12796307.692-118%
Usd Book Value Change Per Share---0.138-0.086-38%-0.424+207%-0.041-71%-0.053-62%
Usd Book Value Per Share---0.192-0.096-50%0.665-129%1.250-115%1.037-118%
Usd Dividend Per Share----0%-0%-0%0.146-100%
Usd Eps---0.250-0.273+9%-0.485+94%-0.445+78%0.197-227%
Usd Free Cash Flow---3462000.000-3401333.333-2%-6969000.000+101%-5286315.789+53%-4344923.077+26%
Usd Free Cash Flow Per Share---0.280-0.276-2%-0.565+101%-0.428+53%-0.352+26%
Usd Free Cash Flow To Equity Per Share---0.203-0.133-34%-0.391+93%-0.011-94%-0.047-77%
Usd Market Cap41063883.060+7%38266710.00048430019.000-21%5117555.258+648%31541254.506+21%25111919.145+52%
Usd Price Per Share3.327+7%3.1003.923-21%0.415+648%2.555+21%2.034+52%
Usd Profit---3089000.000-3370666.667+9%-4667250.000+51%-5202052.632+68%-4454564.103+44%
Usd Revenue--2130000.0002279333.333-7%2151750.000-1%1717052.632+24%1195794.872+78%
Usd Total Gains Per Share---0.138-0.086-38%-0.424+207%-0.041-71%0.094-248%
 EOD+6 -2MRQTTM+7 -25YOY+23 -105Y+18 -1510Y+15 -20

4.2. Fundamental Score

Let's check the fundamental score of Aspira Womens Health Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.323
Price to Book Ratio (EOD)Between0-1-17.363
Net Profit Margin (MRQ)Greater than0-1.450
Operating Margin (MRQ)Greater than0-1.941
Quick Ratio (MRQ)Greater than10.792
Current Ratio (MRQ)Greater than11.031
Debt to Asset Ratio (MRQ)Less than11.378
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.493
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Aspira Womens Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.270
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302024-03-31
Net Debt  -9,4755,454-4,0212,090-1,931-832-2,7633,018255



Latest Balance Sheet

Balance Sheet of 2024-03-31. All numbers in thousands.

Summary
Total Assets6,262
Total Liabilities8,627
Total Stockholder Equity-2,365
 As reported
Total Liabilities 8,627
Total Stockholder Equity+ -2,365
Total Assets = 6,262

Assets

Total Assets6,262
Total Current Assets5,280
Long-term Assets982
Total Current Assets
Cash And Cash Equivalents 2,597
Net Receivables 1,459
Inventory 227
Other Current Assets 997
Total Current Assets  (as reported)5,280
Total Current Assets  (calculated)5,280
+/-0
Long-term Assets
Property Plant Equipment 693
Long-term Assets Other 31
Long-term Assets  (as reported)982
Long-term Assets  (calculated)724
+/- 258

Liabilities & Shareholders' Equity

Total Current Liabilities5,119
Long-term Liabilities3,508
Total Stockholder Equity-2,365
Total Current Liabilities
Short-term Debt 995
Accounts payable 1,261
Other Current Liabilities 2,863
Total Current Liabilities  (as reported)5,119
Total Current Liabilities  (calculated)5,119
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)3,508
Long-term Liabilities  (calculated)0
+/- 3,508
Total Stockholder Equity
Common Stock11
Retained Earnings -518,303
Other Stockholders Equity 515,927
Total Stockholder Equity (as reported)-2,365
Total Stockholder Equity (calculated)-2,365
+/-0
Other
Cash and Short Term Investments 2,597
Common Stock Shares Outstanding 10,408
Liabilities and Stockholders Equity 6,262
Net Debt 255
Net Working Capital 161
Short Long Term Debt Total 2,852



Balance Sheet

All numbers in thousands.

 Trend2024-03-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
0
0
109,459
118,948
118,948
111,179
110,740
106,816
106,816
96,238
90,748
87,615
80,511
76,949
103,669
102,026
94,311
81,174
69,920
74,377
62,311
53,785
59,609
52,811
46,745
40,952
34,643
23,016
23,016
13,155
26,867
24,053
17,555
12,683
7,150
3,858
2,023
1,485
2,600
4,609
38,732
29,898
26,367
24,035
40,907
37,085
28,046
23,111
20,541
18,918
16,882
8,634
6,506
16,891
15,084
30,640
27,272
23,511
18,407
24,174
18,675
12,335
25,389
20,960
15,872
13,899
10,682
8,019
10,442
8,173
9,678
7,497
7,497
16,121
13,474
11,408
11,408
18,152
16,533
13,828
13,828
13,091
21,265
19,605
62,297
55,829
48,047
41,079
30,861
24,016
23,942
17,373
11,496
7,720
8,662
6,262
6,2628,6627,72011,49617,37323,94224,01630,86141,07948,04755,82962,29719,60521,26513,09113,82813,82816,53318,15211,40811,40813,47416,1217,4977,4979,6788,17310,4428,01910,68213,89915,87220,96025,38912,33518,67524,17418,40723,51127,27230,64015,08416,8916,5068,63416,88218,91820,54123,11128,04637,08540,90724,03526,36729,89838,7324,6092,6001,4852,0233,8587,15012,68317,55524,05326,86713,15523,01623,01634,64340,95246,74552,81159,60953,78562,31174,37769,92081,17494,311102,026103,66976,94980,51187,61590,74896,238106,816106,816110,740111,179118,948118,948109,45900
   > Total Current Assets 
0
0
103,891
112,948
112,948
97,506
86,484
81,291
81,291
78,064
63,424
63,150
58,592
51,787
75,021
73,281
65,081
52,200
42,007
57,270
45,660
38,224
44,901
41,146
35,902
31,220
25,790
20,040
20,040
10,575
24,599
17,575
9,815
6,603
2,722
2,821
1,106
656
1,795
3,894
38,063
29,757
26,158
23,829
40,690
36,820
27,797
22,893
20,331
18,732
16,719
8,492
6,377
16,788
14,997
30,249
26,888
23,095
17,877
23,666
18,085
11,710
24,534
19,366
13,931
11,792
8,589
6,108
8,711
6,613
8,303
6,305
6,305
15,286
12,773
10,788
10,788
17,565
16,050
13,410
13,410
12,690
20,251
18,603
61,373
54,907
47,188
40,005
29,800
22,956
22,976
16,309
10,528
6,862
7,572
5,280
5,2807,5726,86210,52816,30922,97622,95629,80040,00547,18854,90761,37318,60320,25112,69013,41013,41016,05017,56510,78810,78812,77315,2866,3056,3058,3036,6138,7116,1088,58911,79213,93119,36624,53411,71018,08523,66617,87723,09526,88830,24914,99716,7886,3778,49216,71918,73220,33122,89327,79736,82040,69023,82926,15829,75738,0633,8941,7956561,1062,8212,7226,6039,81517,57524,59910,57520,04020,04025,79031,22035,90241,14644,90138,22445,66057,27042,00752,20065,08173,28175,02151,78758,59263,15063,42478,06481,29181,29186,48497,506112,948112,948103,89100
       Cash And Cash Equivalents 
0
0
18,010
107,633
107,633
76,949
53,842
48,319
48,319
46,185
32,098
25,145
25,513
19,524
34,057
32,853
29,309
22,766
14,912
35,392
30,058
21,256
28,913
25,738
24,384
20,576
15,024
17,711
17,711
9,553
19,498
7,617
8,283
5,307
1,877
2,464
748
304
1,460
3,440
37,734
28,583
25,292
22,914
40,228
36,285
27,228
22,477
19,850
18,290
16,328
8,007
5,834
16,392
14,604
29,504
25,991
22,186
16,762
22,965
17,241
10,878
23,974
18,642
13,067
11,062
8,080
5,242
7,897
6,028
7,752
5,539
5,539
14,135
11,760
9,360
9,360
16,179
14,636
11,703
11,703
10,935
18,836
16,631
59,369
52,993
44,870
37,180
26,855
20,480
20,551
13,306
7,535
4,246
5,100
2,597
2,5975,1004,2467,53513,30620,55120,48026,85537,18044,87052,99359,36916,63118,83610,93511,70311,70314,63616,1799,3609,36011,76014,1355,5395,5397,7526,0287,8975,2428,08011,06213,06718,64223,97410,87817,24122,96516,76222,18625,99129,50414,60416,3925,8348,00716,32818,29019,85022,47727,22836,28540,22822,91425,29228,58337,7343,4401,4603047482,4641,8775,3078,2837,61719,4989,55317,71117,71115,02420,57624,38425,73828,91321,25630,05835,39214,91222,76629,30932,85334,05719,52425,51325,14532,09846,18548,31948,31953,84276,949107,633107,63318,01000
       Short-term Investments 
0
0
0
0
0
13,621
21,250
21,273
21,273
17,515
13,463
14,713
10,765
8,707
13,847
14,463
10,340
7,021
4,053
2,175
2,190
2,206
2,224
2,240
0
0
0
0
0
0
4,000
8,875
0
0
0
0
0
0
0
0
0
465
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000004650000000008,8754,0000000002,2402,2242,2062,1902,1754,0537,02110,34014,46313,8478,70710,76514,71313,46317,51521,27321,27321,25013,62100000
       Net Receivables 
0
0
84,264
3,024
3,024
3,987
5,726
5,652
5,652
7,765
9,898
13,627
12,607
13,812
16,751
14,787
13,394
8,876
8,836
10,937
4,758
6,758
6,237
5,828
5,070
4,185
3,985
29
29
19
0
19
51
51
31
31
0
0
0
0
24
164
261
136
91
115
114
99
114
107
128
137
184
156
166
373
169
190
179
167
160
165
68
87
117
243
131
275
326
214
221
205
205
707
656
786
786
800
996
924
924
819
848
865
952
1,073
1,103
1,027
1,136
1,112
1,201
1,245
1,554
1,638
1,590
1,459
1,4591,5901,6381,5541,2451,2011,1121,1361,0271,1031,07395286584881992492499680078678665670720520522121432627513124311787681651601671791901693731661561841371281071149911411591136261164240000313151511901929293,9854,1855,0705,8286,2376,7584,75810,9378,8368,87613,39414,78716,75113,81212,60713,6279,8987,7655,6525,6525,7263,9873,0243,02484,26400
       Other Current Assets 
0
0
205
0
969
1,423
1,824
0
2,158
1,832
1,993
2,815
2,766
2,063
2,768
2,878
2,972
3,481
2,886
1,847
1,626
1,462
1,479
1,746
1,442
1,798
2,526
0
2,300
1,003
1,101
1,064
1,481
1,245
814
326
358
352
335
454
305
545
605
779
371
420
455
317
367
335
263
348
359
240
227
372
728
719
936
534
684
667
411
550
676
407
286
498
398
269
175
459
459
334
242
550
550
496
389
0
758
870
522
1,077
981
740
1,078
1,624
1,620
1,173
944
1,442
1,137
398
503
997
9975033981,1371,4429441,1731,6201,6241,0787409811,07752287075803894965505502423344594591752693984982864076765504116676845349367197283722272403593482633353673174554203717796055453054543353523583268141,2451,4811,0641,1011,0032,30002,5261,7981,4421,7461,4791,4621,6261,8472,8863,4812,9722,8782,7682,0632,7662,8151,9931,8322,15801,8241,423969020500
   > Long-term Assets 
0
0
5,568
6,000
6,000
13,673
24,256
25,525
25,525
18,174
27,324
24,465
21,919
25,162
28,648
28,745
29,230
28,974
27,913
17,107
16,651
15,561
14,708
11,665
10,843
9,732
8,853
0
2,976
2,580
2,268
6,478
7,740
6,080
4,428
1,037
917
829
805
715
669
141
209
206
217
265
249
218
210
186
163
142
129
103
87
391
384
416
530
508
590
625
855
1,594
1,941
2,107
2,093
1,911
1,731
1,560
1,375
1,192
1,192
835
701
620
620
587
483
418
418
401
1,014
1,002
924
922
859
1,074
1,061
1,060
966
1,064
968
858
1,090
982
9821,0908589681,0649661,0601,0611,0748599229241,0021,0144014184184835876206207018351,1921,1921,3751,5601,7311,9112,0932,1071,9411,594855625590508530416384391871031291421631862102182492652172062091416697158058299171,0374,4286,0807,7406,4782,2682,5802,97608,8539,73210,84311,66514,70815,56116,65117,10727,91328,97429,23028,74528,64825,16221,91924,46527,32418,17425,52525,52524,25613,6736,0006,0005,56800
       Property Plant Equipment 
0
0
4,570
4,687
4,687
5,786
9,579
10,228
10,228
10,838
12,435
13,370
13,696
13,758
14,279
15,891
15,797
15,863
15,207
9,315
9,044
8,216
7,630
7,320
6,755
5,910
5,435
2,260
2,260
1,889
1,613
1,938
1,630
1,305
742
611
516
426
341
189
143
130
197
194
205
253
237
216
202
186
163
142
121
103
87
391
384
416
530
508
492
535
765
1,504
1,933
2,107
2,093
1,911
1,731
1,549
1,364
1,181
1,181
835
701
608
608
472
399
353
353
360
1,014
989
924
922
859
810
811
753
716
650
570
603
821
693
6938216035706507167538118108599229249891,0143603533533994726086087018351,1811,1811,3641,5491,7311,9112,0932,1071,9331,504765535492508530416384391871031211421631862022162372532051941971301431893414265166117421,3051,6301,9381,6131,8892,2602,2605,4355,9106,7557,3207,6308,2169,0449,31515,20715,86315,79715,89114,27913,75813,69613,37012,43510,83810,22810,2289,5795,7864,6874,6874,57000
       Goodwill 
0
0
0
0
0
0
0
0
0
1,252
2,742
0
2,870
2,870
2,870
0
0
0
3,908
2,529
2,529
2,529
2,529
76
76
76
76
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
392,600
392,800
389,700
388,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000388,600389,700392,800392,60000000000000000000000000000000000000000767676762,5292,5292,5292,5293,9080002,8702,8702,87002,7421,252000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,053,200
8,621,200
8,054,800
7,787,700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000007,787,7008,054,8008,621,2009,053,20000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
455
379
379
227
7,090
6,709
6,709
5,040
7,575
7,496
7,289
10,431
10,144
9,879
10,639
10,397
10,222
5,569
5,440
5,289
5,124
2,493
2,252
2,055
1,856
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
113,500
111,100
104,700
104,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000104,200104,700111,100113,500000000000000000000000000000000000000001,8562,0552,2522,4935,1245,2895,4405,56910,22210,39710,6399,87910,14410,4317,2897,4967,5755,0406,7096,7097,09022737937945500
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
437,200
417,400
634,600
468,100
0
0
0
0
0
0
0
147
115
84
65
49
41
0
0
0
0
0
264
250
307
250
414
0
0
0
0
000041425030725026400000414965841151470000000468,100634,600417,400437,20000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
5,465
5,796
5,796
6,910
12,034
13,587
13,587
15,808
17,105
19,229
20,476
23,168
51,285
53,969
54,036
53,156
50,914
47,662
44,859
45,220
43,875
46,288
45,193
46,479
46,767
32,917
32,917
35,407
34,959
35,515
34,110
33,163
32,015
32,926
33,802
34,925
43,520
31,926
33,221
24,602
21,887
19,419
19,143
19,694
14,871
12,752
11,815
11,753
11,490
3,967
4,229
4,392
4,839
3,874
4,348
5,769
5,832
4,919
3,485
3,114
3,273
3,414
2,995
4,394
4,392
4,257
3,903
3,646
3,757
4,090
4,090
4,053
3,764
4,256
4,256
4,786
4,706
5,090
5,090
5,824
6,715
9,886
9,972
8,991
9,543
10,907
9,117
9,894
12,764
10,642
10,669
8,248
9,321
8,627
8,6279,3218,24810,66910,64212,7649,8949,11710,9079,5438,9919,9729,8866,7155,8245,0905,0904,7064,7864,2564,2563,7644,0534,0904,0903,7573,6463,9034,2574,3924,3942,9953,4143,2733,1143,4854,9195,8325,7694,3483,8744,8394,3924,2293,96711,49011,75311,81512,75214,87119,69419,14319,41921,88724,60233,22131,92643,52034,92533,80232,92632,01533,16334,11035,51534,95935,40732,91732,91746,76746,47945,19346,28843,87545,22044,85947,66250,91453,15654,03653,96951,28523,16820,47619,22917,10515,80813,58713,58712,0346,9105,7965,7965,46500
   > Total Current Liabilities 
0
0
4,602
4,928
4,928
6,088
9,125
10,401
10,401
12,347
13,514
15,483
16,606
17,831
18,685
21,311
21,241
19,826
17,623
17,338
14,885
15,421
12,903
14,016
11,582
11,634
10,738
7,046
7,046
6,393
8,531
9,041
7,718
6,726
5,682
6,548
80
1,241
2,442
4,530
14,606
9,523
13,139
10,103
10,299
11,051
6,386
11,476
10,704
10,756
10,607
3,197
3,573
3,849
4,410
3,558
4,146
5,681
5,832
4,919
3,485
3,114
3,202
3,351
2,940
2,589
2,641
2,561
2,263
2,061
2,229
2,609
2,609
2,666
2,424
2,964
2,964
3,561
3,537
3,978
3,978
4,199
4,615
6,400
6,148
5,791
6,409
7,840
6,139
7,044
7,297
5,775
5,911
5,374
5,162
5,119
5,1195,1625,3745,9115,7757,2977,0446,1397,8406,4095,7916,1486,4004,6154,1993,9783,9783,5373,5612,9642,9642,4242,6662,6092,6092,2292,0612,2632,5612,6412,5892,9403,3513,2023,1143,4854,9195,8325,6814,1463,5584,4103,8493,5733,19710,60710,75610,70411,4766,38611,05110,29910,10313,1399,52314,6064,5302,4421,241806,5485,6826,7267,7189,0418,5316,3937,0467,04610,73811,63411,58214,01612,90315,42114,88517,33817,62319,82621,24121,31118,68517,83116,60615,48313,51412,34710,40110,4019,1256,0884,9284,9284,60200
       Short-term Debt 
0
0
464
416
416
386
571
527
527
440
475
503
501
887
956
986
994
1,081
1,102
941
826
766
584
398
212
22
12
0
0
0
2,460
2,471
2,482
2,494
2,500
2,500
0
0
0
0
2,500
0
5,000
5,000
5,000
5,000
0
7,000
7,000
7,000
7,000
1,106
1,106
1,106
1,106
1,106
1,106
1,106
1,106
1,106
0
0
0
0
0
180
182
182
186
188
191
185
185
187
188
189
189
191
192
193
193
587
485
1,633
1,090
455
256
261
806
611
416
1,244
1,060
753
691
995
9956917531,0601,2444166118062612564551,0901,633485587193193192191189189188187185185191188186182182180000001,1061,1061,1061,1061,1061,1061,1061,1061,1067,0007,0007,0007,00005,0005,0005,0005,00002,50000002,5002,5002,4942,4822,4712,46000012222123985847668269411,1021,08199498695688750150347544052752757138641641646400
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,317,000
817,000
816,000
817,000
0
0
0
0
0
0
0
190
191
192
193
194
587
476
1,610
1,053
403
200
980
742
543
343
1,167
977
565
455
0
04555659771,1673435437429802004031,0531,6104765871941931921911900000000817,000816,000817,0001,317,00000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
1,170
0
919
2,581
3,296
0
3,216
3,504
4,655
5,605
5,715
5,797
4,114
5,062
4,617
6,334
4,603
3,369
2,536
3,593
2,439
3,188
2,390
1,647
2,223
0
2,401
2,620
2,177
2,975
2,648
1,690
1,126
1,676
3
537
985
2,227
2,731
2,150
1,105
998
1,132
1,670
2,162
1,331
714
582
661
525
794
656
422
541
620
1,264
1,144
1,123
1,295
533
803
988
672
503
501
881
568
300
514
745
745
783
495
950
950
811
879
1,158
1,158
1,122
1,315
1,149
1,587
1,436
1,155
1,501
1,298
1,374
1,893
881
867
1,072
1,382
1,261
1,2611,3821,0728678811,8931,3741,2981,5011,1551,4361,5871,1491,3151,1221,1581,1588798119509504957837457455143005688815015036729888035331,2951,1231,1441,2646205414226567945256615827141,3312,1621,6701,1329981,1052,1502,7312,22798553731,6761,1261,6902,6482,9752,1772,6202,40102,2231,6472,3903,1882,4393,5932,5363,3694,6036,3344,6175,0624,1145,7975,7155,6054,6553,5043,21603,2962,58191901,17000
       Other Current Liabilities 
0
0
2,968
0
3,593
2,143
3,670
0
4,636
4,955
5,095
5,514
6,396
6,535
8,331
9,495
9,799
7,132
7,321
7,499
6,791
6,197
5,518
6,298
5,123
6,212
4,934
0
4,600
3,742
3,863
3,568
2,588
2,542
2,056
2,372
77
704
1,457
2,303
10,655
6,058
5,690
3,056
3,234
3,380
3,223
2,592
2,255
2,321
1,870
1,057
964
1,129
1,485
1,241
1,523
2,096
2,078
2,178
2,190
2,581
2,399
2,323
2,268
1,890
1,958
1,494
1,509
1,573
1,462
29
1,679
1,696
1,741
1,825
1,825
2,559
2,466
39
2,627
2,490
2,815
3,618
3,471
3,900
4,998
6,078
4,035
5,059
4,988
3,650
3,984
3,549
3,166
2,863
2,8633,1663,5493,9843,6504,9885,0594,0356,0784,9983,9003,4713,6182,8152,4902,627392,4662,5591,8251,8251,7411,6961,679291,4621,5731,5091,4941,9581,8902,2682,3232,3992,5812,1902,1782,0782,0961,5231,2411,4851,1299641,0571,8702,3212,2552,5923,2233,3803,2343,0565,6906,05810,6552,3031,457704772,3722,0562,5422,5883,5683,8633,7424,60004,9346,2125,1236,2985,5186,1976,7917,4997,3217,1329,7999,4958,3316,5356,3965,5145,0954,9554,63603,6702,1433,59302,96800
   > Long-term Liabilities 
0
0
863
868
868
822
2,909
3,186
3,186
3,461
3,591
3,746
3,870
5,337
32,600
32,658
32,795
33,330
33,291
30,324
29,974
29,799
30,972
32,272
33,611
34,845
36,029
0
25,871
29,014
26,428
26,474
26,392
26,437
26,333
26,378
33,722
33,684
41,078
27,396
18,615
15,079
8,748
9,316
8,844
8,643
8,485
1,276
1,111
997
883
770
656
543
429
316
202
88
0
0
2,190
2,581
71
63
55
1,805
1,751
1,696
1,640
1,585
1,528
1,481
1,481
1,387
1,340
1,292
1,292
1,225
1,169
1,112
1,112
1,625
2,100
3,486
3,824
3,200
3,134
3,067
2,978
2,850
5,467
4,867
4,758
2,874
4,159
3,508
3,5084,1592,8744,7584,8675,4672,8502,9783,0673,1343,2003,8243,4862,1001,6251,1121,1121,1691,2251,2921,2921,3401,3871,4811,4811,5281,5851,6401,6961,7511,8055563712,5812,19000882023164295436567708839971,1111,2768,4858,6438,8449,3168,74815,07918,61527,39641,07833,68433,72226,37826,33326,43726,39226,47426,42829,01425,871036,02934,84533,61132,27230,97229,79929,97430,32433,29133,33032,79532,65832,6005,3373,8703,7463,5913,4613,1863,1862,90982286886886300
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,281
1,225
1,169
1,099
1,050
0
0
3,077
3,428
2,818
2,768
0
0
2,536
0
0
2,204
1,334
0
0
001,3342,204002,536002,7682,8183,4283,077001,0501,0991,1691,2251,2810000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,600,300
8,693,400
8,407,000
8,634,100
0
0
0
0
0
0
0
0
29
21
0
1
10
0
0
0
0
0
0
0
0
2,748
2,280
0
0
0
0
00002,2802,7480000000010102129000000008,634,1008,407,0008,693,4008,600,30000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
103,994
113,152
113,152
104,269
98,706
93,229
93,229
80,430
73,643
68,354
60,035
53,781
52,384
47,892
40,275
28,018
19,006
26,715
17,452
8,565
15,734
6,523
1,552
-5,527
-12,124
0
-9,901
-22,252
-8,092
-11,462
-16,555
-20,480
-24,865
-29,068
-31,779
-33,440
-40,920
-27,317
5,511
5,296
4,480
4,616
21,764
17,391
13,175
10,359
8,726
7,165
5,392
4,667
2,277
12,499
10,245
26,766
22,924
17,742
12,575
19,255
15,190
9,221
22,116
17,546
12,877
9,505
6,290
3,762
6,539
4,527
5,921
3,407
3,407
12,068
9,710
7,152
7,152
13,366
11,827
8,738
8,738
7,267
14,550
9,719
52,325
46,838
38,504
30,172
21,744
14,122
11,178
6,731
827
-528
-659
-2,365
-2,365-659-5288276,73111,17814,12221,74430,17238,50446,83852,3259,71914,5507,2678,7388,73811,82713,3667,1527,1529,71012,0683,4073,4075,9214,5276,5393,7626,2909,50512,87717,54622,1169,22115,19019,25512,57517,74222,92426,76610,24512,4992,2774,6675,3927,1658,72610,35913,17517,39121,7644,6164,4805,2965,511-27,317-40,920-33,440-31,779-29,068-24,865-20,480-16,555-11,462-8,092-22,252-9,9010-12,124-5,5271,5526,52315,7348,56517,45226,71519,00628,01840,27547,89252,38453,78160,03568,35473,64380,43093,22993,22998,706104,269113,152113,152103,99400
   Common Stock
0
0
26
0
27
27
27
0
27
27
27
27
27
29
29
29
29
29
29
29
29
30
36
36
36
36
36
0
39
39
64
6
6
6
6
6
6
6
7
8
10
10
10
11
15
15
15
15
15
15
15
15
15
23
23
36
36
36
36
43
43
42
52
52
52
52
52
52
56
56
60
60
60
75
75
75
75
94
97
97
97
101
104
105
112
112
112
112
112
112
124
125
8
9
11
11
1111981251241121121121121121121051041019797979475757575606060565652525252525242434336363636232315151515151515151511101010876666666643939036363636363029292929292929292727272727027272702600
   Retained Earnings Total Equity00-507,282-504,96500-489,23900-462,767-453,060-445,986-440,06600000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
-1,597
-1,933
-1,933
-1,933
-1,933
-5,928
-5,928
-5,928
-5,928
-2,638
-1,071
-56
758
2,340
2,091
2,300
2,832
-86
-20
-65
-86
-204
-172
-79
-76
-5,912
-71
-40
-102
-221
-640
-277
-80
-162
-236
-173
-106
-46
-47
-104
-159
-156
-157
-155
-152
-153
-156
-154
-154
-263
0
0
0
-334
0
0
0
-452
0
0
0
-654
0
0
0
-1,369
-1,369
0
0
-2,139
-2,139
0
0
-2,750
-2,750
0
0
-2,381
-2,381
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000-2,381-2,38100-2,750-2,75000-2,139-2,13900-1,369-1,369000-654000-452000-334000-263-154-154-156-153-152-155-157-156-159-104-47-46-106-173-236-162-80-277-640-221-102-40-71-5,912-76-79-172-204-86-65-20-862,8322,3002,0912,340758-56-1,071-2,638-5,928-5,928-5,928-5,928-1,933-1,933-1,933-1,933-1,59700
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
414,202
428,226
430,504
430,802
431,072
0
0
449,680
498,199
499,786
501,159
0
0
503,249
0
0
505,784
506,745
0
0
00506,745505,78400503,24900501,159499,786498,199449,68000431,072430,802430,504428,226414,2020000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
176,759
163,947
163,947
166,862
168,215
173,831
173,831
175,492
176,612
174,738
174,048
182,382
185,408
186,043
186,156
186,832
186,817
187,133
187,136
187,334
202,348
202,485
202,946
203,509
203,925
0
207,991
208,482
227,796
227,895
228,067
228,240
228,402
228,560
228,693
228,762
232,229
252,196
296,609
297,149
299,124
303,270
324,706
326,044
326,476
326,796
326,942
327,353
327,601
328,097
328,278
340,609
340,669
359,328
359,139
359,512
359,936
371,137
370,757
369,638
387,669
388,736
388,310
388,687
388,948
390,635
394,712
395,060
398,959
401,539
401,539
413,445
413,739
416,751
416,751
428,226
430,504
0
433,183
436,864
448,431
449,680
498,199
499,786
501,159
501,788
502,628
503,249
504,851
505,504
505,784
506,745
514,544
515,927
515,927514,544506,745505,784505,504504,851503,249502,628501,788501,159499,786498,199449,680448,431436,864433,1830430,504428,226416,751416,751413,739413,445401,539401,539398,959395,060394,712390,635388,948388,687388,310388,736387,669369,638370,757371,137359,936359,512359,139359,328340,669340,609328,278328,097327,601327,353326,942326,796326,476326,044324,706303,270299,124297,149296,609252,196232,229228,762228,693228,560228,402228,240228,067227,895227,796208,482207,9910203,925203,509202,946202,485202,348187,334187,136187,133186,817186,832186,156186,043185,408182,382174,048174,738176,612175,492173,831173,831168,215166,862163,947163,947176,75900



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue9,154
Cost of Revenue-3,892
Gross Profit5,2625,262
 
Operating Income (+$)
Gross Profit5,262
Operating Expense-24,114
Operating Income-18,852-18,852
 
Operating Expense (+$)
Research Development4,035
Selling General Administrative12,267
Selling And Marketing Expenses7,812
Operating Expense24,11424,114
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-73
Net Interest Income73
 
Pretax Income (+$)
Operating Income-18,852
Net Interest Income73
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-16,690-21,014
EBIT - interestExpense = -18,852
-16,690
-16,690
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-18,852-16,690
Earnings Before Interest and Taxes (EBITDA)-18,653
 
After tax Income (+$)
Income Before Tax-16,690
Tax Provision-0
Net Income From Continuing Ops-15,477-16,690
Net Income-16,690
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses28,006
Total Other Income/Expenses Net2,162-73
 

Technical Analysis of Aspira Womens Health Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Aspira Womens Health Inc. The general trend of Aspira Womens Health Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Aspira Womens Health Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Aspira Womens Health Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.6299 < 3.81 < 4.2177.

The bearish price targets are: 2.51 > 2.49 > 2.3087.

Tweet this
Aspira Womens Health Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Aspira Womens Health Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Aspira Womens Health Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Aspira Womens Health Inc.

Aspira Womens Health Inc Daily Moving Average Convergence/Divergence (MACD) ChartAspira Womens Health Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Aspira Womens Health Inc. The current adx is .

Aspira Womens Health Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Aspira Womens Health Inc.

Aspira Womens Health Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Aspira Womens Health Inc.

Aspira Womens Health Inc Daily Relative Strength Index (RSI) ChartAspira Womens Health Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Aspira Womens Health Inc.

Aspira Womens Health Inc Daily Stochastic Oscillator ChartAspira Womens Health Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Aspira Womens Health Inc.

Aspira Womens Health Inc Daily Commodity Channel Index (CCI) ChartAspira Womens Health Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Aspira Womens Health Inc.

Aspira Womens Health Inc Daily Chande Momentum Oscillator (CMO) ChartAspira Womens Health Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Aspira Womens Health Inc.

Aspira Womens Health Inc Daily Williams %R ChartAspira Womens Health Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Aspira Womens Health Inc.

Aspira Womens Health Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Aspira Womens Health Inc.

Aspira Womens Health Inc Daily Average True Range (ATR) ChartAspira Womens Health Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Aspira Womens Health Inc.

Aspira Womens Health Inc Daily On-Balance Volume (OBV) ChartAspira Womens Health Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Aspira Womens Health Inc.

Aspira Womens Health Inc Daily Money Flow Index (MFI) ChartAspira Womens Health Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Aspira Womens Health Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Aspira Womens Health Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Aspira Womens Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.270
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Aspira Womens Health Inc with someone you think should read this too:
  • Are you bullish or bearish on Aspira Womens Health Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Aspira Womens Health Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Aspira Womens Health Inc

I send you an email if I find something interesting about Aspira Womens Health Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Aspira Womens Health Inc.

Receive notifications about Aspira Womens Health Inc in your mailbox!